1McCluskey A, Bowyer MC, Collins E, et al. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity[ J]. Bioorg Med Chem Lett,2000,10 : 1687.
4Stork G,Tamelen EE, Friedman LJ, et al. Cantharidin. a stereospecific total synthesis [ J ]. J Am Chem Soc, 1951,73 ( 9 ) : 4501.
5Stork G, Tamelen EE, Friedman LJ, et al. A stereospecific synthesis of cantharidin [ J ]. J Am Chem Soc, 1953,75 (2) :384.
6Dauben WG, Kessel CR, Takemura KH. Simple, efficient total synthesis of cantharidin via a high - pressure Dials - Alder reaction[ J]. J Am Chem Soc, 1980,102 (22) :6893.
7Dauben WG, Krabbenhoft HO. Organic reactions at high pressure. Cycloadditions with furans [ J]. J Am Chem Soc, 1976,98 (7) :1992.
9Sim Alistair TR, Ackland S, Sakoff J. Anhydride modified cantharidin analogues useful in the treatment of cancer[ P]. Australian Patent :2004203476, 2004-08-26.
10McCluskey A ,rella AK,Cecilia CW, et al. The First Two Cantharidin Analogues Displaying PP1 Selectivity [ J ]. Bioorg Med Chem Lett,2002,12:391.
9Charrier L, Jorry A, Toquet C, et al. Growth phase-dependent expression of ICAD-L/DEF45 modulates the pattern of apoptosis in human colonic cancer cells[J]. Cancer Res, 2002, 62(7):2169-2172.
10Kim YM, Talaninan RV, Billiar TR, et al. Nitric oxide inhibits apoptosis by preventing increases on caspase-3-like activity via two distinct mechanism[J]. J Biol Chem, 1997, 272(49):31138-31147.
